A FDA advisory panel has recommended the agency approve VertiFlex's Superion interspinous spacer system for the treatment of spinal stenosis.
A FDA advisory panel has recommended the agency approve VertiFlex Inc.'s Superion interspinous spacer system for the treatment of spinal stenosis.
According to VertiFlex, the panel based their vote largely on results from the company's 470-patient clinical trial.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1a7nrRu
Cap comentari:
Publica un comentari a l'entrada